Day: July 9, 2025

CALGARY, Alberta, July 09, 2025 (GLOBE NEWSWIRE) — CEMATRIX Corporation (TSX: CEMX) (OTCQB: CTXXF) (“CEMATRIX” or the “Company“), a specialty construction contractor that produces cellular concrete solutions on site and is a leading manufacturer and supplier of cellular concrete in North America announced today that it has mobilized to a project work site in North Carolina and started to pour cellular concrete. “The start of this important project marks a long awaited, key milestone for our Company,” stated Randy Boomhour, President and CEO of CEMATRIX Corporation. “In the normal course of business, we generally do not disclose or discuss projects before they start or while they are underway, however we have made an exception for this project given the significance of the project.” “Our focus remains on...

HOUSTON, July 09, 2025 (GLOBE NEWSWIRE) — APA Corporation (Nasdaq: APA) today provided supplemental information regarding certain second-quarter 2025 financial and operational results. This information is intended only to provide additional information regarding current estimates management believes will affect results for the second-quarter 2025. It is provided to assist investors, analysts and others in formulating their own estimates, and is not intended to be a comprehensive presentation of all factors that will affect second-quarter 2025 results. Actual results and the impact of factors identified here may vary depending on the impact of other factors not identified here and are subject to finalization of the financial reporting process for second-quarter 2025.Estimated Average Realized Prices – 2Q25  Oil (bbl) NGL (bbl) Natural...

HOUSTON, July 09, 2025 (GLOBE NEWSWIRE) — Crown Castle Inc. (NYSE: CCI) (“Crown Castle”) plans to release its second quarter 2025 results on Wednesday, July 23, 2025, after the market closes. In conjunction with the release, Crown Castle has scheduled a conference call for Wednesday, July 23, 2025, at 5:30 p.m. eastern time. A listen only live audio webcast of the conference call, along with any supplemental materials, can be accessed on the Crown Castle website at https://investor.crowncastle.com. Participants may join the conference call by dialing 833-816-1115 (Toll Free) or 412-317-0694 (International) at least 30 minutes prior to the start time. All dial-in participants should ask to join the Crown Castle call. A replay of the webcast will be available on the Investor page of Crown Castle’s website until end of...

BOSTON, July 09, 2025 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare neuroendocrine diseases, today announced a proposed public offering of $150 million of its common stock. All securities in the offering will be offered by Rhythm. In addition, Rhythm intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of shares of common stock at the public offering price, less the underwriting discounts and commissions. Morgan Stanley, BofA Securities, Stifel and Wells Fargo Securities are acting as joint book-running managers for the proposed offering. Canaccord Genuity and Citizens Capital Markets are acting as lead managers for the offering. The offering...

HOUSTON, July 09, 2025 (GLOBE NEWSWIRE) — KBR (NYSE: KBR) today announced that Byron Bright has resigned from his position as Chief Operating Officer (COO) and will leave the company on July 11, 2025. KBR would like to thank Mr. Bright for his 15 years of dedicated service. He has been an integral part of KBR’s transformation and success, and we wish him well in his next chapter. In January 2025, KBR announced a realignment of its portfolio into two business segments, Mission Technology Solutions (MTS) and Sustainable Technology Solutions (STS). In connection with this realignment, Mr. Bright moved into the COO role from his previous position as President of MTS, and the company appointed new leadership for the MTS business segment. Doug Hill became President of KBR’s Readiness & Sustainment business, and Mark Kavanaugh became...

RADNOR, Pa., July 09, 2025 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2025 after the market close on Wednesday, August 6th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET. Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance. A live and archived webcast of the event will be available on the “Investors” section of the Certara website at https://ir.certara.com/. About CertaraCertara accelerates medicines using biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical...